Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis

The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibro...

Full description

Saved in:
Bibliographic Details
Published inASAIO journal (1992) Vol. 62; no. 4; p. 498
Main Authors Xuereb, Linnea, Go, Pauline H, Kaur, Babbaljeet, Akrawe, Silvy, Borgi, Jamil, Paone, Gaetano, Morgan, Jeffrey A
Format Journal Article
LanguageEnglish
Published United States 01.07.2016
Subjects
Adult
Aged
Heart-Assist Devices
Humans
Liver Cirrhosis - mortality
Male
Middle Aged
Multivariate Analysis
Online AccessGet more information

Cover

More Information
Summary:The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).
ISSN:1538-943X
DOI:10.1097/MAT.0000000000000375